Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
Co-occurring health disorders appear to contribute to increased risk, NIH study suggests.
Health officials remain concerned about HIV and hepatitis C transmissions during COVID-19.
A West Virginia drive-through event does exactly that—plus give free Naloxone trainings.
We’ve reported on STI clinics closing, but harm reduction advocates are also raising alarms—and trying to reach those most vulnerable.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.